Quick Takeaways
- Natasha Hernday has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $444,801.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Natasha Hernday
- Location
- Incline Village, NV
- Summary
- The estimated net worth of Natasha Hernday is at least $444,801 dollars as of 13 Jun 2025. Natasha Hernday is the Director of Janux Therapeutics, Inc. and owns shares of Janux Therapeutics, Inc. (JANX) stock worth about $223.2K. Natasha Hernday is the Director of XOMA Royalty Corp and owns shares of XOMA Royalty Corp (XOMA) stock worth about $221.6K.
- Signature
- /s/ James Pennington, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Natasha Hernday and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Janux Therapeutics, Inc. ($223,164).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Natasha Hernday
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | Director | $223,164 | 11 Jun 2025 | ||
| XOMA, XOMAO | XOMA Royalty Corp | Director | $221,637 | 21 May 2025 | ||
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Director | 20 May 2024 |
Insider Transactions Reported by Natasha Hernday:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.